| IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis E Hams, ME Armstrong, JL Barlow, SP Saunders, C Schwartz, G Cooke, ... Proceedings of the National Academy of Sciences 111 (1), 367-372, 2014 | 383 | 2014 |
| Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation EC Lavelle, E McNeela, ME Armstrong, O Leavy, SC Higgins, KHG Mills The Journal of Immunology 171 (5), 2384-2392, 2003 | 201 | 2003 |
| The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis DN O’Dwyer, ME Armstrong, G Trujillo, G Cooke, MP Keane, PG Fallon, ... American journal of respiratory and critical care medicine 188 (12), 1442-1450, 2013 | 176 | 2013 |
| Rheumatoid arthritis (RA) associated interstitial lung disease (ILD) DN O'Dwyer, ME Armstrong, G Cooke, JD Dodd, DJ Veale, SC Donnelly European journal of internal medicine 24 (7), 597-603, 2013 | 139 | 2013 |
| Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent EC Lavelle, A Jarnicki, E McNeela, ME Armstrong, SC Higgins, O Leavy, ... Journal of Leucocyte Biology 75 (5), 756-763, 2004 | 125 | 2004 |
| Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis C Moore, RZ Blumhagen, IV Yang, A Walts, J Powers, T Walker, M Bishop, ... American journal of respiratory and critical care medicine 200 (2), 199-208, 2019 | 102 | 2019 |
| IL‐1F5 mediates anti‐inflammatory activity in the brain through induction of IL‐4 following interaction with SIGIRR/TIR8 C Costelloe, M Watson, A Murphy, K McQuillan, C Loscher, ME Armstrong, ... Journal of neurochemistry 105 (5), 1960-1969, 2008 | 98 | 2008 |
| Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer L Mawhinney, ME Armstrong, C O’Reilly, R Bucala, L Leng, ... Molecular Medicine 20, 729-735, 2014 | 76 | 2014 |
| Macrophage migration inhibitory factor (MIF), enzymatic activity and the inflammatory response G Cooke, ME Armstrong, SC Donnelly Biofactors 35 (2), 165-168, 2009 | 66 | 2009 |
| Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis H Adamali, ME Armstrong, AM McLaughlin, G Cooke, E McKone, ... American journal of respiratory and critical care medicine 186 (2), 162-169, 2012 | 64 | 2012 |
| Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines ME Armstrong, EC Lavelle, CE Loscher, MA Lynch, KHG Mills Journal of Infectious Diseases 192 (9), 1628-1633, 2005 | 59 | 2005 |
| Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase … ME Armstrong, M Gantier, L Li, WY Chung, A McCann, JA Baugh, ... The Journal of Immunology 180 (11), 7125-7133, 2008 | 46 | 2008 |
| Identification of novel genes in human airway epithelial cells associated with chronic obstructive pulmonary disease (COPD) using machine-based learning algorithms S Mostafaei, A Kazemnejad, S Azimzadeh Jamalkandi, S Amirhashchi, ... Scientific reports 8 (1), 15775, 2018 | 34 | 2018 |
| Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis DN O’Dwyer, ME Armstrong, M Kooblall, SC Donnelly Expert opinion on therapeutic targets 19 (4), 507-514, 2015 | 27 | 2015 |
| IL-1β-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity ME Armstrong, CE Loscher, MA Lynch, KHG Mills Journal of neuroimmunology 136 (1-2), 25-33, 2003 | 27 | 2003 |
| Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis G Cooke, I Kamal, M Strengert, E Hams, L Mawhinney, A Tynan, ... QJM: An International Journal of Medicine 111 (4), 217-224, 2018 | 18 | 2018 |
| Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis A Tynan, L Mawhinney, ME Armstrong, C O’Reilly, S Kennedy, E Caraher, ... The FASEB Journal 31 (11), 5102, 2017 | 17 | 2017 |
| Candidate role for Toll-like receptor 3 L412F polymorphism and infection in acute exacerbation of idiopathic pulmonary fibrosis AN McElroy, R Invernizzi, JW Laskowska, A O’Neill, M Doroudian, ... American journal of respiratory and critical care medicine 205 (5), 550-562, 2022 | 14 | 2022 |
| MIF is a common genetic determinant of COVID-19 symptomatic infection and severity JJ Shin, W Fan, J Par-Young, M Piecychna, L Leng, K Israni-Winger, ... QJM: An International Journal of Medicine 116 (3), 205-212, 2023 | 13 | 2023 |
| Age-related alterations in basal expression and in vitro, tumour necrosis factor alpha mediated, upregulation of CD11b ME Armstrong, HD Alexander, JL Ritchie, SA McMillan, IM Rea Gerontology 47 (4), 180-185, 2001 | 12 | 2001 |
